Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients

Author:

Antar Annukka A R1ORCID,Yu Tong1,Pisanic Nora2,Azamfirei Razvan1,Tornheim Jeffrey A1,Brown Diane M1,Kruczynski Kate2,Hardick Justin P1,Sewell Thelio1,Jang Minyoung1,Church Taylor1,Walch Samantha N1,Reuland Carolyn1,Bachu Vismaya S1,Littlefield Kirsten3,Park Han-Sol3,Ursin Rebecca L4,Ganesan Abhinaya3,Kusemiju Oyinkansola1,Barnaba Brittany1,Charles Curtisha1,Prizzi Michelle1,Johnstone Jaylynn R1,Payton Christine1,Dai Weiwei1,Fuchs Joelle1,Massaccesi Guido1,Armstrong Derek T5,Townsend Jennifer L1,Keller Sara C1,Demko Zoe O1ORCID,Hu Chen6,Wang Mei-Cheng7,Sauer Lauren M8,Mostafa Heba H4,Keruly Jeanne C1,Mehta Shruti H9,Klein Sabra L34,Cox Andrea L136,Pekosz Andrew3ORCID,Heaney Christopher D2910,Thomas David L1,Blair Paul W1,Manabe Yukari C13

Affiliation:

1. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

2. Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

3. W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

4. Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

5. Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

6. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

7. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

8. Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

9. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

10. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

Abstract

Abstract Background Sustained molecular detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in the upper respiratory tract (URT) in mild to moderate coronavirus disease 2019 (COVID-19) is common. We sought to identify host and immune determinants of prolonged SARS-CoV-2 RNA detection. Methods Ninety-five symptomatic outpatients self-collected midturbinate nasal, oropharyngeal (OP), and gingival crevicular fluid (oral fluid) samples at home and in a research clinic a median of 6 times over 1–3 months. Samples were tested for viral RNA, virus culture, and SARS-CoV-2 and other human coronavirus antibodies, and associations were estimated using Cox proportional hazards models. Results Viral RNA clearance, as measured by SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR), in 507 URT samples occurred a median (interquartile range) 33.5 (17–63.5) days post–symptom onset. Sixteen nasal-OP samples collected 2–11 days post–symptom onset were virus culture positive out of 183 RT-PCR-positive samples tested. All participants but 1 with positive virus culture were negative for concomitant oral fluid anti-SARS-CoV-2 antibodies. The mean time to first antibody detection in oral fluid was 8–13 days post–symptom onset. A longer time to first detection of oral fluid anti-SARS-CoV-2 S antibodies (adjusted hazard ratio [aHR], 0.96; 95% CI, 0.92–0.99; P = .020) and body mass index (BMI) ≥25 kg/m2 (aHR, 0.37; 95% CI, 0.18–0.78; P = .009) were independently associated with a longer time to SARS-CoV-2 viral RNA clearance. Fever as 1 of first 3 COVID-19 symptoms correlated with shorter time to viral RNA clearance (aHR, 2.06; 95% CI, 1.02–4.18; P = .044). Conclusions We demonstrate that delayed rise of oral fluid SARS-CoV-2-specific antibodies, elevated BMI, and absence of early fever are independently associated with delayed URT viral RNA clearance.

Funder

JHU COVID-19 Research and Response Program Fund

Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3